To test whether the nuclear translocation of NF-κB was related to migration and invasion activities of CCA cells, dehydroxymethylepoxyquinomicin (DHMEQ), a specific inhibitor of nuclear translocation of NF-κB21, was used for this purpose. This evidence concerns the gene NFKB1 and cholangiocarcinoma.